IBIsrael Bedzina

Israel Bedzina

*This is an algorithmically generated author record based on publicly available information.

Israel Bedzina has a total of 15 co-authors. Here are the top co-authors by number of shared publications:

  • Gameli Nudo

    Affiliation Laboratory Department, Ho Teaching Hospital, Ho, Ghana

    2 shared publications
  • John Gameli Deku

    Department of Medical Laboratory Sciences, School of Allied Health Sciences University of Health and Allied Sciences Ho Ghana

    2 shared publications
  • Prosper Mensah

    Affiliation Laboratory Department, Ho Teaching Hospital, Ho, Ghana

    2 shared publications
  • Aaron Osei-Tutu

    Affiliation Department of Medical Laboratory Sciences, School of Allied Health Sciences, University of Health and Allied Sciences, Ho, Ghana

    1 shared publication
  • Agnes Naa Larley Lartey

    Affiliation Department of Medical Laboratory Sciences, School of Allied Health Sciences, University of Health and Allied Sciences, Ho, Ghana

    1 shared publication
  • Emmanuel Ativi

    Affiliation Laboratory Department, Ho Teaching Hospital, Ho, Ghana

    1 shared publication

Latest Publications

  • Open Access

    Prevalence of rifampicin resistance in pulmonary tuberculosis: A laboratory-based study

    by Israel Bedzina, Agnes Naa Larley Lartey, Lois Kwaley-Buabeng, Prosper Mensah, Gameli Nudo, Eric Selorm Odum, Rita Sewornu, Kenneth Ablordey, John Gameli Deku, Kwabena Obeng Duedu

    Tuberculosis (TB) remains a significant global public health challenge, particularly in low- and middle-income countries. The emergence of rifampicin-resistant tuberculosis further complicates control efforts. Despite national efforts, there are limited data on the prevalence of Mycobacterium tuberculosis and their rifampicin resistance in Ghana, especially at the facility level. This study aimed to determine the prevalence of Mycobacterium tuberculosis and rifampicin resistance among presumptive tuberculosis cases at the Ho Teaching Hospital over a three-year period. The study used a retrospective design and collected secondary data from the Microbiology Laboratory Unit of Ho Teaching Hospital between 2022 and 2024. Data on patient demographics, Mycobacterium tuberculosis detection, and rifampicin resistance were retrieved and analysed using descriptive and inferential statistics. Mycobacterium tuberculosis and rifampicin resistance were identified using the GeneXpert MTB/RIF assay. Statistical analyses were performed using STATA version 15 with statistical significance set at p < 0.05. Out of 2,225 presumptive tuberculosis cases, 203 tested positive for the infection, resulting in an overall prevalence of 9.1% (95% CI: 7.9–10.4). The prevalence was significantly higher among males (12.4%) compared to females (5.7%), and highest among young adults aged 18–24 years (12.8%). Of the 166 Mycobacterium tuberculosis- positive cases tested for rifampicin susceptibility, 3 (1.8%) were resistant. Although rifampicin resistance was more common among females and adults, the differences were not statistically significant. Although the detection rate of rifampicin resistance among newly diagnosed Mycobacterium tuberculosis cases was low (1.8%), it remains a significant public health concern, hence the need for enhancing surveillance systems and prioritising early detection strategies.


  • Open Access

    Trends of Mycobacterium tuberculosis and rifampicin resistance at the Ho Teaching Hospital in Ghana

    by John Gameli Deku, Enoch Aninagyei, Israel Bedzina, Gameli Nudo, Emmanuel Ativi, Prosper Mensah, Solomon Wireko, Aaron Osei-Tutu, Emmanuel Duker, Innocent Afeke

    Background: Tuberculosis remains a major public health threat worldwide, causing significant morbidity and mortality, particularly in low- and middle-income countries. In recent years, efforts to combat tuberculosis have focused on strengthening healthcare systems and increasing access to diagnostics and treatment services. There is scarcity of data on the prevalence of Mycobacterium tuberculosis and rifampicin-resistant tuberculosis in the Volta region of Ghana. Therefore, the aim of this study was to determine the trends of Mycobacterium tuberculosis and rifampicin resistance in a major teaching hospital in Ghana spanning a six-year period. Methodology: A retrospective cross-sectional hospital study was conducted at Ho Teaching Hospital, Ho, Ghana. Study data included archived results on tuberculosis testing using GeneXpert from 2016–2021. Archived data on tuberculosis testing were collected and entered using Microsoft Excel 2019. IBM SPSS (v26) was used for a statistical analysis of the prevalence of tuberculosis. P-value <0.05 was considered statistically significant. Results: The study included 5128 presumptive tuberculosis cases from 2016 to 2021, of which 552 were positive, revealing an overall prevalence of 10.76%. Males exhibited a significantly higher prevalence of tuberculosis (14.20%) compared to females (7.48%), with a male-to-female ratio of 2:1. The burden of tuberculosis varied significantly between age groups, with those aged 30–45 years and 46–60 years facing twice the risk compared to those under 15 years (p<0.001). Rainy seasons correlated with heightened tuberculosis occurrences (12.12%) compared to dry seasons (8.84%) (p = 0.008). Rifampicin-resistant tuberculosis was prevalent at 3.45%, slightly higher in women, particularly in the 45–59 age group (5.97%). In particular, tuberculosis prevalence exhibited fluctuations, peaking in 2016 (17.1%) and 2020 (11.5%), with a trough in 2019 (4.6%). Conclusion: The overall prevalence of laboratory confirmed tuberculosis was 10.76%, and resistance to rifampicin, 3.45%, indicating high infection and possible treatment failure. Considering its infectious nature, this calls for concerted efforts to curb the spread of the infection.